99 related articles for article (PubMed ID: 599117)
1. Cefuroxime: antimicrobial activity, human pharmacokinetics and therapeutic efficacy.
Daikos GK; Kosmidis JC; Stathakis C; Giamarellou H
J Antimicrob Chemother; 1977 Nov; 3(6):555-62. PubMed ID: 599117
[No Abstract] [Full Text] [Related]
2. Cefuroxime: pharmacokinetics after a short infusion, and in vitro activity against hospital pathogens.
Goodwin CS; Dash CH; Hill JP; Goldberg AD
J Antimicrob Chemother; 1977 May; 3(3):253-61. PubMed ID: 873875
[No Abstract] [Full Text] [Related]
3. [Cefuroxime, a new antibiotic. Action in vitro and in vivo].
Orsolini P; Xerri L
G Ital Chemioter; 1977; 24(1-2):49-55. PubMed ID: 615762
[No Abstract] [Full Text] [Related]
4. Studies with cefuroxime and cefoxitin.
Geddes AM; McGhie D; Ball AP; Gould I
Scand J Infect Dis Suppl; 1978; (13):78-81. PubMed ID: 308260
[TBL] [Abstract][Full Text] [Related]
5. Clinical and pharmacokinetic studies on cefuroxime.
Norrby R; Foord RD; Hedlund P
J Antimicrob Chemother; 1977 Jul; 3(4):355-62. PubMed ID: 893243
[No Abstract] [Full Text] [Related]
6. Laboratory evaluation of BL-S786, a cephalosporin with broad-spectrum antibacterial activity.
Leitner F; Misiek M; Pursiano TA; Buck RE; Chisholm DR; DeRegis RG; Tsai YH; Price KE
Antimicrob Agents Chemother; 1976 Sep; 10(3):426-35. PubMed ID: 984784
[TBL] [Abstract][Full Text] [Related]
7. Studies with cefuroxime: a new beta-lactamase resistant cephalosporin.
Ball AP; Brookes GR; Farrell ID; Geddes AM; Gould I
Chemotherapy; 1979; 25(4):214-21. PubMed ID: 110540
[TBL] [Abstract][Full Text] [Related]
8. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
Brorson JE; Norrby R
Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
[No Abstract] [Full Text] [Related]
9. Activities of cefoperazone, cefotaxime, cefuroxime, and cephalothin against 128 clinical isolates.
Garcia-Rodriguez JA
Clin Ther; 1980; 3(Spec Issue):117-22. PubMed ID: 6248220
[No Abstract] [Full Text] [Related]
10. [Minimal inhibitory and bactericidal concentrations of cefoperazone, cefotaxime, cefuroxime and cefalotin against 90 bacterial strains].
Mascellino MT; Prignano G; Iegri F; Lorenzi A
Boll Ist Sieroter Milan; 1982; 61(4):309-19. PubMed ID: 6100234
[TBL] [Abstract][Full Text] [Related]
11. Cefuroxime: antimicrobial activity, Pharmacology, and clinical efficacy.
Smith BR; LeFrock JL
Ther Drug Monit; 1983 Jun; 5(2):149-60. PubMed ID: 6349019
[TBL] [Abstract][Full Text] [Related]
12. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae.
Phillips I; Shannon K
Scand J Infect Dis Suppl; 1978; (13):23-6. PubMed ID: 98833
[TBL] [Abstract][Full Text] [Related]
13. [Cefuroxim, a new beta-lactamase stable cephalosporin].
Simon C
Schweiz Med Wochenschr; 1978 Sep; 108(36):1398-403. PubMed ID: 309178
[TBL] [Abstract][Full Text] [Related]
14. Use of cefoxitin sodium in difficult-to-treat infections.
Ramachandran Nair S; Cherubin CE
J Antimicrob Chemother; 1978 Jul; 4(B):167-78. PubMed ID: 357383
[No Abstract] [Full Text] [Related]
15. [Clinico-microbiologic bases for the use of new cephalosporins].
De Bac C; Mascellino MT; Nuti M
Minerva Med; 1982 Apr; 73(15):899-903. PubMed ID: 6979006
[No Abstract] [Full Text] [Related]
16. Determination of plasma and renal clearance of cefuroxime and its pharmacokinetics in renal insufficiency.
van Dalen R; Vree TB; Hafkenscheid JC; Gimbrère JS
J Antimicrob Chemother; 1979 May; 5(3):281-92. PubMed ID: 479064
[No Abstract] [Full Text] [Related]
17. Cefoxitin sodium therapy of anaerobic infections.
Busch DF; Heseltine PN; Meyer RD; Sutter VL; Finegold SM
J Antimicrob Chemother; 1978 Jul; 4(B):197-202. PubMed ID: 357386
[No Abstract] [Full Text] [Related]
18. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
Thabaut A; Durosoir JL; Saliou P
Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
[TBL] [Abstract][Full Text] [Related]
19. Cephaloglycine as a urinary antimicrobial in patients with reduced renal function.
Lowentritt L; Schlegel JU; Domingue GJ
J Urol; 1971 Nov; 106(5):615-8. PubMed ID: 5115708
[No Abstract] [Full Text] [Related]
20. Cefoxitin, a new semi-synthetic cephamycin: an in-vitro and in-vivo comparison with cephalothin.
Kosmidis J; Hamilton-Miller JM; Gilchrist JN; Kerry DW; Brumfitt W
Br Med J; 1973 Dec; 4(5893):653-5. PubMed ID: 4202265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
